{"id":203135,"name":"PRIME THERAPEUTICS","slug":"prime-therapeutics","state":"MN","country":"United States of America","description":"Pharmacy Benefit Management","totalSpending":828000,"filings":29,"yearlySpending":[{"year":2019,"income":108000},{"year":2020,"income":120000},{"year":2021,"income":120000},{"year":2022,"income":120000},{"year":2023,"income":120000},{"year":2024,"income":120000},{"year":2025,"income":120000}],"issues":["HCR","MMM","BUD"],"firms":["GOVERNMENT COUNSEL, LLC"],"lobbyists":["HENRY MENN"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Issues relating to pharmaceutical value-based contracting and rebate transparency.","H.R 1781- Payment Commission Data Act of 2019; H.R. 965 & S. 340-The CREATES Act of 2019; issues relating to orphan drug exclusivity and value-based contracting; RIN 0936-AA08: Fraud and Abuse; Remova","General issues relating to PBM point of sale rebates, spread pricing and price transparency.","RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in ","H.R. 2113-Prescription Drug STAR Act of 2019;H.R. 2296-More Efficient Tools to Realize Information for Consumers (METRIC) Act;S. 1895-Lower Health Care Costs ActSection 306;S. 2543-The Prescription Dr"],"years":[2019,2020,2021,2022,2023,2024,2025]}